BACKGROUND Chronic hepatitis C (CHC) is associated with systemic insulin resistance, yet there are limited data on the tissue-specific contribution in vivo to this adverse metabolic phenotype, and the effect of HCV cure. METHODS We examined tissue-specific insulin sensitivity in a cohort study involving 13 patients with CHC compared to 12 BMI-matched healthy control subjects. All subjects underwent a two-step clamp incorporating the use of stable isotopes to measure carbohydrate and lipid flux (hepatic and global insulin sensitivity) with concomitant subcutaneous adipose tissue microdialysis and biopsy (subcutaneous adipose tissue insulin sensitivity). Investigations were repeated in seven patients with CHC following antiviral ther...
Insulin resistance is the main clinical and pathogenetic feature of the metabolic syndrome, one of t...
Hepatitis C virus (HCV) infection can lead to increased insulin resistance, but the dynamics of insu...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis C feature steatosis and i...
Background Chronic hepatitis C (CHC) is associated with systemic insulin resistance, yet there are l...
Background & Aims: Chronic hepatitis C (CHC) is associated with insulin resistance (IR), liver steat...
Hepatitis C virus (HCV) infection is associated with insulin resistance, which may lead to type 2 di...
This review will focus on the impact of steatosis and insulin resistance on the response to antivira...
Chronic hepatitis C (CHC) has been associated with type 2 diabetes and insulin resistance, but the e...
Chronic hepatitis C (CHC) has been associated with type 2 diabetes and insulin resistance, but the e...
Hepatitis C virus (HCV) infection is associated with insulin resistance, which may lead to type 2 di...
BackgroundThe increased incidence of type 2 diabetes mellitus among hepatitis C virus (HCV) infected...
Background and Aim: Chronic hepatitis C virus (HCV), particularly genotype 1, is associated with ins...
The role of insulin resistance in predicting virological response to therapy of chronic hepatitis C ...
BACKGROUND:The increased incidence of type 2 diabetes mellitus among hepatitis C virus (HCV) infecte...
Original abstract: Background & aims. Chronic hepatitis C is associated with an increased preval...
Insulin resistance is the main clinical and pathogenetic feature of the metabolic syndrome, one of t...
Hepatitis C virus (HCV) infection can lead to increased insulin resistance, but the dynamics of insu...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis C feature steatosis and i...
Background Chronic hepatitis C (CHC) is associated with systemic insulin resistance, yet there are l...
Background & Aims: Chronic hepatitis C (CHC) is associated with insulin resistance (IR), liver steat...
Hepatitis C virus (HCV) infection is associated with insulin resistance, which may lead to type 2 di...
This review will focus on the impact of steatosis and insulin resistance on the response to antivira...
Chronic hepatitis C (CHC) has been associated with type 2 diabetes and insulin resistance, but the e...
Chronic hepatitis C (CHC) has been associated with type 2 diabetes and insulin resistance, but the e...
Hepatitis C virus (HCV) infection is associated with insulin resistance, which may lead to type 2 di...
BackgroundThe increased incidence of type 2 diabetes mellitus among hepatitis C virus (HCV) infected...
Background and Aim: Chronic hepatitis C virus (HCV), particularly genotype 1, is associated with ins...
The role of insulin resistance in predicting virological response to therapy of chronic hepatitis C ...
BACKGROUND:The increased incidence of type 2 diabetes mellitus among hepatitis C virus (HCV) infecte...
Original abstract: Background & aims. Chronic hepatitis C is associated with an increased preval...
Insulin resistance is the main clinical and pathogenetic feature of the metabolic syndrome, one of t...
Hepatitis C virus (HCV) infection can lead to increased insulin resistance, but the dynamics of insu...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis C feature steatosis and i...